Aims The role of aspirin in patients with coronary artery disease (CAD) is well established,
yet patients happen to discontinue aspirin according to physician's advice or unsupervised …

Objectives: We sought to determine whether aspirin withdrawal is an encountered situation
in coronary disease patients who relapsed. Background: Despite the recognized benefits of …

Background: There are increasing concerns about risks associated with aspirin
discontinuation in the absence of major surgery or bleeding. We investigated whether long …

Long-term therapy with low-dose aspirin (acetylsalicylic acid; ASA), 75–325 mg, is highly
effective for the secondary prevention of cardiovascular (CV) events. For high-CV-risk …

OBJECTIVES: We investigated the hypothesis that biological aspirin “resistance” may often
be related to noncompliance in patients undergoing coronary stenting. BACKGROUND …

BACKGROUND: A lack of aspirin effect on platelets after a myocardial infarction (MI) is
associated with poor health outcome. This lack of effect may be due to biological resistance …

Background: The primary aim of this article was to explore, in subgroup analyses, whether
participants with differing frequencies of aspirin consumption in a randomized, double-blind …

Four decades have passed since the first trial suggesting the efficacy of aspirin in the
secondary prevention of myocardial infarction. Further trials, collectively summarized by the …

Background—The goal of the present study was to assess national trends and patterns of
aspirin use among outpatients with coronary artery disease. Although there is strong …

Objectives To evaluate the risk of myocardial infarction and death from coronary heart
disease after discontinuation of low dose aspirin in primary care patients with a history of …